Seeking Alpha

GSK launches fund to invest in bioelectronics

  • GSK (GSK) has launched a $50M VC fund that will invest in the nascent field of "bioelectronics" or "electroceuticals" in which implants will use the electrical impulses in the body's nervous system to fight disease rather than drugs.
  • The fund's first investment will be in California-based SetPoint Medical, which is developing devices to treat inflammatory diseases.
  • The long term hope is to be able to treat a variety of illnesses, including high blood-pressure, breathing problems and eventually brain disorders. (Previous)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs